B + L Announces Publication of Phase 4 Data on the Early Effects of MIEBO® on Patient-Reported Outcomes in Dry Eye Disease in Ophthalmology and Therapy Journal
Thursday, March 20 2025 | 14 h 20 min | News
Bausch + Lomb Corporation announced Ophthalmology and Therapy has published results from a phase 4 study which assessed early patient-reported...
Read More
CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions
Wednesday, December 11 2024 | 09 h 24 min | News
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc have announced the signing of a Memorandum of Understanding (MoU) to...
Read More Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
Wednesday, July 10 2024 | 11 h 08 min | News
Bausch + Lomb Corporation shared results from the company’s inaugural State of Dry Eye survey, which explores dry eye understanding and...
Read More
WCO and Alcon Extend Global Partnership for Dry Eye Disease Education
Wednesday, June 5 2024 | 14 h 27 min | News
The World Council of Optometry (WCO) and Alcon are extending their education initiative to advance global, evidence-based dry eye disease education,...
Read More
CORE Publication Helps ECPs Prepare for a New Wave of Dry Eye Disease Medications
Friday, April 19 2024 | 14 h 59 min | News
In response to accelerating clinical interest about new, innovative treatments for dry eye disease, the Centre for Ocular Research & Education...
Read More
